NCT00198315View on ClinicalTrials.gov

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

PHASE3TerminatedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

June 1, 2007

Conditions
Head and Neck Cancer
Interventions
COMBINATION_PRODUCT

Medpulser electroporation with Bleomycin

Patients receive electroporation with injection of bleomycin sulfate at a concentration of 1 U/ml per cm3 of tumor treatment area.

PROCEDURE

Tumor surgical excision

Patients have their tumor surgically removed.

Trial Locations (1)

92121

Inovio Biomedical Corporation, San Diego

Sponsors
All Listed Sponsors
lead

Inovio Pharmaceuticals

INDUSTRY

NCT00198315 - Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter